Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma
2021-07-22 09:27
INEOS Styrolution advances China's circular economy target through collaboration with GER to produce Terluran ECO GP-22
2021-07-22 09:00
Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants
2021-07-22 08:37
China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma
2021-07-22 08:30
CGTN selects Top 200 Media Challengers globally
2021-07-22 00:18
AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA
2021-07-21 21:02
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company
2021-07-21 18:37
China Literature to Report First Half 2021 Financial Results on August 16, 2021
2021-07-21 17:00
Globaltality Holdings and HuaCan DreamWorks Sign Agreement to Expand Access to Coworking Spaces and Services across Greater China
2021-07-21 16:52
Straive Introduces Straive Data Platform (SDP): An End-to-End Data Management Platform Focused on Unstructured Data Solutions
2021-07-21 12:30
GAC MOTOR Russia Brand Strategy of "GO AND CHANGE"
2021-07-21 10:45
Ahead of the Games in Tokyo: Moviebook Shares Insights on Trending Sports and Education Technologies
2021-07-21 10:43
vivo Conducts Inaugural Overseas 5G Standalone Network Tests in Thailand with AIS
2021-07-21 10:00
Prodigy Technovations Announces QSPI, SMI, SM Bus, JTAG Exerciser and Protocol Analyzer
2021-07-21 00:00
Launching of Zhejiang International Media Convergence Campaign in Celebration of the 100th Anniversary of the Founding of the Communist of China
2021-07-20 22:27
HONOR Announced the Usage of Qualcomm Snapdragon 888 Plus and Revealed Design Concept of HONOR Magic3 Series
2021-07-20 20:34
Nisun International Announces Strategic Collaboration with Zhongneng Shanhua Energy to Jointly Develop Supply Chain Services in the Energy Industry
2021-07-20 20:00
German Olympic Dressage team on the way to make it a fabulous 14
2021-07-20 19:08
Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China
2021-07-20 18:42
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership
2021-07-20 18:00
1
485
486
487
488
489
1140